Talks
Carvykti Efficacy & Response Rates
July 30, 2026
Share
Post-Discharge CAR-T Toxicities
July 30, 2026
Share
ICANS: Managing Neurologic Toxicity After CAR T-Cell Infusion
July 30, 2026
Share
Managing Cytokine Release Syndrome: Tocilizumab and Steroid Therapy
July 30, 2026
Share
Cytokine Release Syndrome: A Key CAR T-Cell Toxicity
July 30, 2026
Share
CAR T-Cell Infusion: Scheduling and Administration
July 30, 2026
Share
Lymphodepletion: Preparing the Patient for CAR T-Cell Infusion
July 30, 2026
Share
CAR T-Cell Therapy: The Future of Multiple Myeloma Treatment
July 30, 2026
Share
CAR T-Cell Timing: Moving to Earlier Lines of Myeloma Therapy
July 30, 2026
Share
CARTITUDE-1: Five-Year Remission Data in Heavily Pretreated Myeloma
July 30, 2026
Share
CAR T-Cell Therapy: Mechanism of Action in Myeloma
July 30, 2026
Share
CAR T-Cell Therapy in Myeloma: Targeting BCMA
July 30, 2026
Share
Close button
Why are you reporting this TALK?